Conference item icon

Conference item

The impact of a virtual clinic on clinical decision-making and healthcare resource use vs. standard care: The Oxford experience

Abstract:
Optimisation of infliximab (IFX) therapy using proactive therapeutic drug monitoring (TDM) in inflammatory bowel disease (IBD) may reduce drug costs and improve clinical outcomes. The Oxford Virtual Clinic (VC) for biological therapy TDM was started in March 2016. Levels are monitored with each infusion and therapy optimised if clinically appropriate.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1093/ecco-jcc/jjx180.695

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM Experimental Medicine
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDM Experimental Medicine
Role:
Author
Expand authors...
National Institute for Health Research More from this funder
Publisher:
Oxford University Press Publisher's website
Journal:
13th Congress of the European Crohn's and Colitis Organisation (ECCO 2018) Journal website
Host title:
13th Congress of the European Crohn's and Colitis Organisation (ECCO 2018)
Publication date:
2018-01-26
Acceptance date:
2017-12-22
DOI:
ISSN:
1873-9946 and 1876-4479
Source identifiers:
844192
Pubs id:
pubs:844192
UUID:
uuid:5c218101-2593-4227-9abc-e329ea37b5d1
Local pid:
pubs:844192
Deposit date:
2018-04-27

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP